When using CD20-CD3 TCEs in the presence of T cells, i-TCE is a more potent bispecific T cell engager than c-TCE, most likely due to the highly efficient CD20 binding and closer spatial contact of cancer cells with T cells24. This evidence concerns the gene MS4A1 and cancer.